Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginie Marcel

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Oncotarget|May 19, 2017
Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanismZeina Bash-Imam, Gabriel Thérizols, Anne Vincent, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Evidence for rRNA 2'-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomesJenny Erales, Virginie Marchand, Baptiste Panthu, et al.
JAMA Oncology|May 13, 2022
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical TrialPierre Heudel, Jean-Sébastien Frenel, Cécile Dalban, et al.
Breast Cancer Research : BCR|November 13, 2025
Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancerCamille Jouines, Piero Lo Monaco, Angéline Gaucherot, et al.
Molecular Oncology|November 12, 2022
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO groupNour-El-Houda Mourksi, Cécile Dalban, Amélie Colombe-Vermorel, et al.
Cancer Cell|September 14, 2013
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancerVirginie Marcel, Sandra E Ghayad, Stéphane Belin, et al.
Molecular Cell|February 5, 2019
Ribosomal Proteins Regulate MHC Class I Peptide Generation for ImmunosurveillanceJiajie Wei, Rigel J Kishton, Matthew Angel, et al.
Cancers|November 21, 2018
Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer CellsMarie Alexandra Albaret, Claudine Vermot-Desroches, Arnaud Paré, et al.
Hemasphere|June 8, 2026
A RiboCancer cell line panel reveals that CLL-associated Rps15 mutations translationally rewire transcription through codon-specific tRNA accommodation defectsAnaïs Astier, Marino Caruso, Stijn Vereecke, et al.
NAR Cancer|January 29, 2025
Specific modulation of 28S_Um2402 rRNA 2'-<i>O</i>-ribose methylation as a novel epitranscriptomic marker of ZEB1-induced epithelial-mesenchymal transition in different mammary cell contextsChloé Morin, Hermes Paraqindes, Flora Nguyen Van Long, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Oncotarget|May 19, 2017
Translational reprogramming of colorectal cancer cells induced by 5-fluorouracil through a miRNA-dependent mechanismZeina Bash-Imam, Gabriel Thérizols, Anne Vincent, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Evidence for rRNA 2'-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomesJenny Erales, Virginie Marchand, Baptiste Panthu, et al.
JAMA Oncology|May 13, 2022
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical TrialPierre Heudel, Jean-Sébastien Frenel, Cécile Dalban, et al.
Breast Cancer Research : BCR|November 13, 2025
Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancerCamille Jouines, Piero Lo Monaco, Angéline Gaucherot, et al.
Molecular Oncology|November 12, 2022
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO groupNour-El-Houda Mourksi, Cécile Dalban, Amélie Colombe-Vermorel, et al.
Cancer Cell|September 14, 2013
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancerVirginie Marcel, Sandra E Ghayad, Stéphane Belin, et al.
Molecular Cell|February 5, 2019
Ribosomal Proteins Regulate MHC Class I Peptide Generation for ImmunosurveillanceJiajie Wei, Rigel J Kishton, Matthew Angel, et al.
Cancers|November 21, 2018
Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer CellsMarie Alexandra Albaret, Claudine Vermot-Desroches, Arnaud Paré, et al.
Hemasphere|June 8, 2026
A RiboCancer cell line panel reveals that CLL-associated Rps15 mutations translationally rewire transcription through codon-specific tRNA accommodation defectsAnaïs Astier, Marino Caruso, Stijn Vereecke, et al.
NAR Cancer|January 29, 2025
Specific modulation of 28S_Um2402 rRNA 2'-<i>O</i>-ribose methylation as a novel epitranscriptomic marker of ZEB1-induced epithelial-mesenchymal transition in different mammary cell contextsChloé Morin, Hermes Paraqindes, Flora Nguyen Van Long, et al.
Pageof 6